Work

Supplemental Figure 2 from Clinical Dosing Regimen of Selinexor Maintains Normal Immune Homeostasis and T-cell Effector Function in Mice: Implications for Combination with Immunotherapy

Year: 2023
Type: supplementary-materials
Abstract: Supplemental Figure 2: IFNγ secretion is impaired by selinexor.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4362595096
Cites:
Cited by:
Related to: 10